Trial Profile

An Observational Study of BOTOX for the Management of Urinary Incontinence in Patients With Idiopathic Overactive Bladder

Status: Completed

Phase of Trial: Phase IV

Latest Information Update: 21 Jun 2022

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Botulinum-Toxin-A (Primary)
Indications Overactive bladder; Urinary incontinence
Focus Therapeutic Use
Acronyms GRACE
Sponsors Allergan

Most Recent Events

16 May 2022 Results presented at the 117th Annual Meeting of the American Urological Association
22 Nov 2020 Results presented at the 50th Annual Meeting of the International Continence Society
22 Nov 2020 Results assessing methodologies used for onabotulinumtoxinA administration for treatment of patients with overactive bladder presented at the 50th Annual Meeting of the International Continence Society

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com